Filing metadata

Accession number
0000902664-26-000675
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Feb 03, 2026
Reporting period
Dec 10, 2025
Description
Insider transaction

Explore SEC Filings Hub